Immediate Impact

1 by Nobel laureates 58 standout
Sub-graph 1 of 24

Citing Papers

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
7 intermediate papers

Works of Jason Jiang being referenced

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
2018 Nobel
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors
2017
and 5 more

Author Peers

Author Last Decade Papers Cites
Jason Jiang 307 67 99 97 28 558
H. Kiener 172 46 84 31 31 626
Bjørn I. Bertelsen 213 122 56 30 31 643
Junyu Lu 182 62 78 18 37 643
Elisabeth del Río 256 14 89 52 24 618
Ankit Garg 204 44 59 37 24 566
Lijuan Xu 250 123 28 67 39 541
Joana Rita Carvalho 179 127 38 31 26 543
Daisuke Shima 268 34 25 58 27 578
Philip A. DeSimone 118 36 69 88 16 608
Visalini Nair‐Shalliker 181 87 105 48 29 641

All Works

Loading papers...

Rankless by CCL
2026